| ADCC | Antibody-dependent cellular cytotoxicity |
| AI | Artificial intelligence |
| CDC | Complement-dependent cytolysis |
| COBRA | Computationally optimized broadly reactive antigen |
| CTLs | Cytotoxic T lymphocytes |
| HA | Hemagglutinin |
| IAVs | Influenza A viruses |
| IIV3 | Inactivated influenza vaccines |
| LAIV3 | Live-attenuated influenza vaccine |
| LNPs | Lipid nanoparticles |
| M1 | Matrix protein |
| M2e | M2 extracellular domain |
| MHC | Major histocompatibility complex |
| MPLA | Monophosphoryl lipid A |
| MVA | Modified Ankara |
| NP | Nucleoprotein |
| PB1 | Polymerase basic protein 1 |
| PEG | Polyethylene glycol |
| PLGA | Poly lactic-co-glycolic acid |
| PROTAC | Proteolysis-targeting chimeric |
| PROTAR | Proteolysis-targeting |
| RIV3 | Recombinant influenza vaccine |
| saRNA | Self-amplifying RNA |
| TLR | Toll-like receptor |
| vRNA | Viral RNA |